Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-08T04:40:10.302Z Has data issue: false hasContentIssue false

Development of a protective device for RT-PCR testing SARS-CoV-2 in COVID-19 patients

Published online by Cambridge University Press:  13 April 2020

Tomoya Tsuchida*
Affiliation:
Division of General Internal Medicine, St Marianna University School of Medicine, Miyamae, Kawasaki, Japan
Shigeki Fujitani
Affiliation:
Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Miyamae, Kawasaki, Japan
Yukitaka Yamasaki
Affiliation:
Department of Infectious Diseases, St Marianna University School of Medicine, Miyamae, Kawasaki, Japan
Hiroyuki Kunishima
Affiliation:
Department of Infectious Diseases, St Marianna University School of Medicine, Miyamae, Kawasaki, Japan
Takahide Matsuda
Affiliation:
Division of General Internal Medicine, St Marianna University School of Medicine, Miyamae, Kawasaki, Japan
*
Author for correspondence: Tomoya Tsuchida, E-mail: t2tsuchida@marianna-u.ac.jp
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

To the Editor—In December 2019, the novel coronavirus SARS-CoV-2 emerged in Wuhan City, Hubei Province, China, and has now spread worldwide.1 Currently, the diagnostic gold standard is the reverse transcription-polymerase chain reaction (RT-PCR). From the sensitivity perspective, sputum samples are preferable for examination.Reference Wang, Xu and Gao2 If acquiring a sputum sample is difficult, a healthcare worker (HCW) can collect sample from the nasopharynx.3 Getting a sample from the nasopharynx may carry a risk of the patient sneezing or coughing, and the HCW could be potentially exposed to the virus. Therefore, HCWs are required to wear personal protective equipment (PPE) for each examination and procedure. However, PPE is difficult to don and doff, and donning and doffing carries the risk of infection. Furthermore, if the demand for RT-PCR increases under conditions in which medical resources are scarce, it might be difficult to sample and test all specimens.

On March 14, 2020, we developed a protective box (product name, Star Ball Shield) to be used in patients with suspected COVID-19 during clinical examinations or performance of RT-PCR in collaboration with Star Ball Company, Kitakyushu City, Japan (Figure 1). The shield was made by processing waterproof cardboard and is collapsible and easy to carry.

Furthermore, the Star Ball Shield permits HCWs to run RT-PCR without the risk of exposure. This shield liberates the HCWs from the need to don and doff PPE for each clinical examination.

Once a patient’s examination has concluded, the HCW uses alcohol to wipe the surface of the box facing the patient and proceeds to examine the next patient. The Star Ball Shield is extremely helpful in the examination of patients with suspected COVID-19.

Fig. 1. The photo shows the healthcare worker (HCW) and patient sides of the shield. An acrylic plate is used for the window so that the patient’s face can be seen clearly. The HCW wears PPE for examinations but does not need to change PPE for each patient. The disposable gloves used for testing must be changed for each patient.

Acknowledgments

We are grateful to Star Ball Company for collaborating in the development of the Star Ball Shield and for providing it to our hospital.

Financial support

No financial support was provided relevant to this article.

Conflicts of interest

All authors report no conflicts of interest relevant to this article.

References

World Health Organization: Novel coronavirus (2019-nCoV) situation report-1. World Health Organization website. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4. Published January 21, 2020. Accessed March 13, 2020Google Scholar
Wang, W, Xu, Y, Gao, R, et al.Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 2020 Mar 11. doi: 10.1001/jama.2020.3786.CrossRefGoogle ScholarPubMed
A Manual for sampling and transmission of specimens from patients with suspected 2019-nCoV (Novel coronavirus) [in Japanese]. Japanese National Institute of Infectious Diseases. https://www.niid.go.jp/niid/ja/diseases/ka/corona-virus/2019-ncov/9325-manual-200121.html. Published 2020. Accessed March 13, 2020.Google Scholar
Figure 0

Fig. 1. The photo shows the healthcare worker (HCW) and patient sides of the shield. An acrylic plate is used for the window so that the patient’s face can be seen clearly. The HCW wears PPE for examinations but does not need to change PPE for each patient. The disposable gloves used for testing must be changed for each patient.